GEODE CAPITAL MANAGEMENT, LLC

Position in CNSP — CNS Pharmaceuticals, Inc.

CIK 1214717 BOSTON, MA

Position in CNSP

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$55,421

+$40,678 QoQ

Shares Held

23,189

+1457.4% QoQ

Ownership

1.59%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,017,848	$2,989,245,636
2	REGN	Regeneron Pharmaceuticals, Inc.	2,625,810	$1,637,297,566
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,635,840	$793,466,914
4	RVMD	Revolution Medicines, Inc.	3,942,676	$738,384,360
5	MRNA	Moderna, Inc.	9,710,335	$680,014,759
6	INCY	Incyte Corp	4,750,735	$538,543,319
7	RPRX	Royalty Pharma plc	8,058,048	$451,814,751
8	INSM	INSMED Inc	4,220,155	$449,952,925

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$55,421	23,189	+29.8%	Shares	Defined	2026-05-15
2025-06-30	$14,743	17,871	-95.4%	Shares	Defined	2025-08-08
2024-12-31	$46,447	387,064	+90.5%	Shares	Defined	2025-02-12
2024-09-30	$26,616	203,180	+619.1%	Shares	Defined	2024-11-12
2024-03-31	$10,227	28,254	+15.6%	Shares	Defined	2024-05-13
2023-12-31	$31,033	24,436	0.0%	Shares	Defined	2024-02-13
2023-09-30	$27,857	24,436	+51.4%	Shares	Defined	2023-11-13
2023-06-30	$35,996	16,142	-87.5%	Shares	Defined	2023-08-11
2022-09-30	—	129,016	0.0%	Shares	Defined	2022-11-14
2022-06-30	$36,124	129,016	0.0%	Shares	Defined	2022-08-12
2022-03-31	$43,220	129,016	+20.3%	Shares	Defined	2022-05-13
2021-12-31	—	107,262	0.0%	Shares	Defined	2022-02-11
2021-09-30	—	107,262	+7.1%	Shares	Defined	2021-11-12
2021-06-30	—	100,196	+64.8%	Shares	Defined	2021-08-13
2021-03-31	—	60,784	—	Shares	Defined	2021-05-12
No filing history on record for this holder in this stock.